Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Comparison of lead bioavailability in F344 rats fed lead acetate, lead oxide, lead sulfide, or lead ore concentrate from Skagway, Alaska

Journal Article · · Journal of Toxicology and Environmental Health; (United States)
;  [1];  [2];  [3]
  1. National Institute of Environmental Health Sciences, Research Triangle Park, NC (United States)
  2. Research Triangle Institute, Research Triangle Park, NC (United States)
  3. Radian Corporation, Research Triangle Park, NC (United States)
An animal model using rats was developed to initiate investigations on the bioavailability of different sources of environmental lead. Lead must be absorbed and transported to target organs like brain, liver, kidney, and bone, before susceptible cells can be harmed. The bioavailability and therefore the toxicity of lead are dependent upon the route of exposure, dose, chemical structure solubility, particle size, matrix incorporation, and other physiological and physicochemical factors. In the present study male F344 rats were fed [<=] 38 [mu]m size particles of lead sulfide, lead oxide, lead acetate, and a lead ore concentrate from Skagway, Alaska, mixed into the diet at doses of 0, 10, 30, an 100 ppm as lead for 30 d. No morality or overt symptoms of lead toxicity were observed during the course of the study. Maximum blood lead concentrations attained in the 100 ppm groups were [approximately]80 [mu]g/dl in rats fed lead acetate and lead oxide and were [approximately]10 [mu]g/dl in those fed lead sulfide and lead ore concentrate. Maximum bone lead levels in rats fed soluble lead oxide and lead acetate were much higher ([approximately] 200 [mu]g/g) that those seen in rats fed the less soluble lead sulfide and lead ore ([approximately]10 [mu]g); kidney lead concentrations were also about 10-fold greater in rats fed the more soluble compared to the less soluble lead compounds. However, strong correlations between dose and tissue lead concentrations were observed in rats fed each of the four different lead compounds. Kidney lesions graded as minimal occurred in 7/10 rats fed 30 ppm and in 10/10 rats fed 100 ppm lead acetate, but not at lower doses or from other lead compounds. Similarly, urinary aminolevulinic acid excretion, a biomarker for lead toxicity, was increased in rats fed 100 ppm lead acetate or lead oxide, but was unaffected at lower doses or by the less soluble lead compounds. 25 refs., 6 figs., 2 tabs.
OSTI ID:
7033631
Journal Information:
Journal of Toxicology and Environmental Health; (United States), Journal Name: Journal of Toxicology and Environmental Health; (United States) Vol. 39:1; ISSN 0098-4108; ISSN JTEHD6
Country of Publication:
United States
Language:
English

Similar Records

Relative bioavailability of lead from mining waste soil in rats
Journal Article · Thu Oct 01 00:00:00 EDT 1992 · Fundamental and Applied Toxicology; (United States) · OSTI ID:6994844

Lead, hypertension, and the renin-angiotensin system in rats
Journal Article · Sun Feb 28 23:00:00 EST 1982 · J. Lab. Clin. Med.; (United States) · OSTI ID:5524321

Effects of low lead exposure on neuro-behavioral function in the rat
Journal Article · Fri Dec 31 23:00:00 EST 1982 · Arch. Environ. Health; (United States) · OSTI ID:5706210